| Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis
|
(Genmab)
|
10-Jun-2008 |
| Preliminary Data from Ongoing Phase 1 Trial of Investigational Fully Human Anti-PD-1 Antibody “ONO-4538/MDX-1106” Presented at American Society of Clinical Oncology
|
(Ono Pharmaceutical)
|
03-Jun-2008 |
| Updated CDX-110 Data in Glioblastoma Multiforme Presented at 44th Annual ASCO Annual Meeting
|
(Pfizer)
|
02-Jun-2008 |
| Cell Genesys Reports Updated Results From Phase 1 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Used in Combination With Ipilimumab
|
(Cell Genesys)
|
02-Jun-2008 |
| Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting
|
(Medarex)
|
02-Jun-2008 |
| Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
|
(Medarex)
|
02-Jun-2008 |
| New Ipilimumab Survival Data in Patients with Metastatic Melanoma Presented at American Society of Clinical Oncology Annual Meeting
|
(Bristol-Myers Squibb)
|
01-Jun-2008 |
| New Ipilimumab Survival Data in Patients with Metastatic Melanoma Presented at American Society of Clinical Oncology Annual Meeting
|
(Medarex)
|
01-Jun-2008 |
| Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma
|
(Medarex)
|
01-Jun-2008 |
| Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
|
(Genmab)
|
30-May-2008 |
| Genmab Announces Updates on Phase III Cancer Studies
|
(Genmab)
|
29-May-2008 |
| Medarex Reports Phase 1 Clinical Data of MDX-1100 at Digestive Disease Week
|
(Medarex)
|
21-May-2008 |
| Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
|
(Medarex)
|
12-May-2008 |
| Confidence in Medarex's ipilimumab dented again
|
(Medarex)
|
28-Apr-2008 |
| Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
|
(Medarex)
|
25-Apr-2008 |
| Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
|
(Bristol-Myers Squibb)
|
25-Apr-2008 |
| Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting
|
(Medarex)
|
16-Apr-2008 |
| Medarex Reports Preclinical Data on Multiple Antibody-Drug Conjugate Candidates at American Association for Cancer Research Meeting
|
(Medarex)
|
16-Apr-2008 |
| Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
|
(Genmab)
|
15-Apr-2008 |
| Cell Genesys Reports Data on an Association Between Immune Response and Anti-Tumor Activity in Patients Receiving GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010)
|
(Cell Genesys)
|
15-Apr-2008 |
| Significant Tumor-Specific Immune Response Observed in AVANT's Phase 2 Trial Evaluating CDX-110 with Temozolomide for Treatment of Glioblastoma Multiforme
|
(AVANT Immunotherapeutics)
|
15-Apr-2008 |
| Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
|
(Medarex)
|
15-Apr-2008 |
| ACZ885, a New Biological Drug in Development, Shows Potential in Treating Serious Life-long Autoinflammatory Diseases
|
(Novartis)
|
08-Apr-2008 |
| Medarex Announces Ipilimumab Program Continues to Move Forward
|
(Medarex)
|
03-Apr-2008 |
| Pfizer's melanoma disappointment compounds Medarex misery
|
(Medarex)
|
02-Apr-2008 |
| Medarex to Receive Milestone Payment from Novo Nordisk
|
(Medarex)
|
31-Mar-2008 |
| Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
|
(Medarex)
|
20-Mar-2008 |
| Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
|
(Schering-Plough)
|
18-Mar-2008 |
| Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab In Europe For the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
|
(Johnson & Johnson)
|
18-Mar-2008 |
| Novel Anti-CD20 Monoclonal Antibody Ofatumumab Demonstrates Anti-Tumour Responses in Patients With Relapsed/Refractory B-Cell Chronic Lymphocytic Leukaemia
|
(GlaxoSmithKline)
|
08-Feb-2008 |
| Centocor Announces Ustekinumab Biologic License Application Accepted For Filing By FDA
|
(Johnson & Johnson)
|
04-Feb-2008 |
| Promising Phase 3 Data for Ustekinumab (CNTO 1275) in Long-Term Improvement of Chronic Plaque Psoriasis
|
(Johnson & Johnson)
|
04-Feb-2008 |
| Medarex Announces Allowance of Investigational New Drug Application for Wholly Owned Fully Human Anti-CD70 Antibody, MDX-1411
|
(Medarex)
|
08-Jan-2008 |
| Medarex to Receive Milestone Payment from Amgen
|
(Medarex)
|
18-Dec-2007 |
| Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis
|
(Genmab)
|
13-Dec-2007 |
| Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
|
(Genmab)
|
13-Dec-2007 |
| One more throw of the dice for ipilimumab
|
(Medarex)
|
12-Dec-2007 |
| Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma
|
(Medarex)
|
10-Dec-2007 |
| Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma
|
(Bristol-Myers Squibb)
|
10-Dec-2007 |
| Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
|
(Medarex)
|
07-Dec-2007 |
| Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
|
(Johnson & Johnson)
|
04-Dec-2007 |
| Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
|
(Medarex)
|
04-Dec-2007 |
| Genmab Announces Update on Recruitment of Patients in Ofatumumab CLL Pivotal Study
|
(Genmab)
|
28-Nov-2007 |
| GlaxoSmithKline and Genmab Initiate Ofatumumab Rheumatoid Arthritis Phase III Programme
|
(GlaxoSmithKline)
|
20-Nov-2007 |
| FibroGen Announces New Research in HIF and CTGF Therapeutic Programs Presented at the Annual Meeting of the American Society of Nephrology
|
(FibroGen)
|
08-Nov-2007 |
| Medarex Announces Presentations on UltiMAb(R) Antibodies at 71st Annual Meeting of the American College of Rheumatology
|
(Medarex)
|
08-Nov-2007 |
| FibroGen Announces New Research in HIF and CTGF Therapeutic Programs Presented at the Annual Meeting of the American Society of Nephrology
|
(FibroGen)
|
07-Nov-2007 |
| Initiation of Development of “ONO-4538/MDX-1106”, Fully Human Anti-PD-1 Antibody for Hepatitis C in US
|
(Ono Pharmaceutical)
|
30-Oct-2007 |
| Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
|
(Medarex)
|
29-Oct-2007 |
| Genmab’s HuMax-CD4 Displays Unique Mechanism of Action
|
(Genmab)
|
15-Oct-2007 |
| Genmab Amends HuMax-CD4 Pivotal Study in CTCL
|
(Genmab)
|
11-Oct-2007 |
| Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study
|
(Genmab)
|
27-Sep-2007 |
| DAHANCA Initiates Head and Neck Cancer Study With Genmab’s HuMax-EGFr
|
(Genmab)
|
13-Sep-2007 |
| Genmab Discloses Target and Development Plans for HuMax-Inflam
|
(Genmab)
|
13-Sep-2007 |
| Genmab Announces Encouraging Preclinical Data for Ofatumumab
|
(Genmab)
|
07-Sep-2007 |
| Preliminary Data Add New Mechanistic Insights to Activity of Anthrax Anti-Toxin, Valortim(TM)
|
(Medarex)
|
31-Jul-2007 |
| Medarex Announces Advancement of Antibody Development by Partner
|
(Medarex)
|
19-Jul-2007 |
| MedImmune Advances Potential Treatment for Patients With Lupus
|
(AstraZeneca)
|
19-Jul-2007 |
| Medarex Announces Initiation by Licensing Partner of Phase III Clinical Trial for Muckle Wells Syndrome
|
(Medarex)
|
18-Jul-2007 |
| Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid Arthritis Study
|
(Schering-Plough)
|
14-Jun-2007 |
